Mesoblast Ltd SEC filings MEOBF
Mesoblast Ltd has 598 filings in SEC EDGAR's recent list, going back to Nov 8, 2005. Its latest annual report, Form 20-F, was filed on Aug 27, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 3 | Initial insider ownership | Apr 29, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 9, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 16, 2026 | Mar 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 11, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 16, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 12, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 16, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 11, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | May 3, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 3, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 20, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 6, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 6, 2023 | — |
| SC 13G | Ownership over 5% (passive) | May 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 20, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 6, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 8, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 19, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 3, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 30, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 5, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 31, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Oct 31, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 12, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Apr 12, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2016 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MESO (Nasdaq), MEOBF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne, Victoria, Australia
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1345099
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.